STAT3 Silencing as a Novel Therapeutic Strategy for Activated B Cell-Type Diffuse Large B-Cell Lymphoma

被引：0
|
作者：
Scuto, Anna [1 ]
Kujawski, Maciej [1 ]
Kowolik, Claudia [1 ]
Yu, Hua [1 ]
Forman, Stephen [1 ]
Jove, Richard [1 ]
机构：
[1] City Hope Comprehens Canc Ctr, Beckman Res Inst, Duarte, CA USA
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：381 / 382
页数：2
相关论文
共 50 条
  • [1] STAT3 Inhibition Is a Therapeutic Strategy for ABC-like Diffuse Large B-Cell Lymphoma
    Scuto, Anna
    Kujawski, Maciej
    Kowolik, Claudia
    Krymskaya, Ludmila
    Wang, Lin
    Weiss, Lawrence M.
    DiGiusto, David
    Yu, Hua
    Forman, Stephen
    Jove, Richard
    CANCER RESEARCH, 2011, 71 (09) : 3182 - 3188
  • [2] Constitutively activation of STAT3 is a prognostic factor in activated B-cell subtype of diffuse large B-cell lymphoma
    Huang, Xin
    Cao, Wenfeng
    Igbal, Javeed
    Meng, Bin
    Ding, B. Belinda
    Bi, Chengfeng
    Jiang, Chunsun
    Ye, B. Hilda
    Chan, Wing C.
    Fu, Kai
    CANCER RESEARCH, 2012, 72
  • [3] The Positivity of Phosphorylated STAT3 Is a Novel Marker for Favorable Prognosis in Germinal Center B-Cell Type of Diffuse Large B-Cell Lymphoma
    Morichika, Kazuho
    Karube, Kennosuke
    Sakihama, Shugo
    Watanabe, Risa
    Kawaki, Mamoru
    Nishi, Yukiko
    Nakachi, Sawako
    Okamoto, Shiki
    Takahara, Taishi
    Satou, Akira
    Shimada, Satoko
    Shimada, Kazuyuki
    Tsuzuki, Toyonori
    Fukushima, Takuya
    Morishima, Satoko
    Masuzaki, Hiroaki
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2021, 45 (06) : 832 - 840
  • [4] Difference in expression of STAT3 and STAT5b in Swedish and Egyptian patients with activated b-cell subtype of diffuse large b-cell lymphoma
    Jacobson, Therese
    Bahnassy, Abeer A.
    Lundahl, Joachim
    Tamm, Katja Prokovskaja
    Porwit, Anna
    Zekri, Abdel-Rahman N.
    Khaled, Hussein M.
    Mellstedt, Hkan
    Moshfegh, Ali
    CANCER RESEARCH, 2011, 71
  • [5] Interplay Between Histone Deacetylases (HDACs) and STAT3: Mechanism of Activated JAK/STAT3 Oncogenic Pathway in ABC (Activated B-cell) Type Diffuse Large B Cell Lymphoma
    Gupta, Mamta
    Stenson, Mary
    Lasho, Terra
    Tefferi, Ayalew
    Novak, Anne
    Ansell, Stephen M.
    Witzig, Thomas E.
    BLOOD, 2009, 114 (22) : 381 - 381
  • [6] Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas
    Ding, B. Belinda
    Yu, J. Jessica
    Yu, Raymond Y. -L.
    Mendez, Lourdes M.
    Shaknovich, Rita
    Zhang, Yonghui
    Cattoretti, Giorgio
    Ye, B. Hilda
    BLOOD, 2008, 111 (03) : 1515 - 1523
  • [7] Phosphorylated STAT3 and survivin expression in Diffuse Large B-Cell Lymphoma (DLBCL)
    Song, J. Y.
    Kim, G. Y.
    Lim, S. J.
    Lee, S.
    Park, J. H.
    Park, Y. K.
    Kim, Y. W.
    Lee, J. H.
    MODERN PATHOLOGY, 2008, 21 : 276A - 276A
  • [8] Phosphorylated STAT3 and survivin expression in diffuse large B-cell lymphoma (DLBCL)
    Sung, J. Y.
    Kim, G. Y.
    Lim, S. J.
    Lee, S.
    Park, J. H.
    Park, Y. K.
    Kim, Y. W.
    Lee, J. H.
    LABORATORY INVESTIGATION, 2008, 88 : 276A - 276A
  • [9] Fbw7 regulates apoptosis in activated B-cell like diffuse large B-cell lymphoma by targeting Stat3 for ubiquitylation and degradation
    Yao, Su
    Xu, Fangping
    Chen, Yu
    Ge, Yan
    Zhang, Fen
    Huang, Huijie
    Li, Li
    Lin, Danyi
    Luo, Xinlan
    Xu, Jie
    Luo, Donglan
    Zhu, Xiaolan
    Liu, Yanhui
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36
  • [10] Fbw7 regulates apoptosis in activated B-cell like diffuse large B-cell lymphoma by targeting Stat3 for ubiquitylation and degradation
    Su Yao
    Fangping Xu
    Yu Chen
    Yan Ge
    Fen Zhang
    Huijie Huang
    Li Li
    Danyi Lin
    Xinlan Luo
    Jie Xu
    Donglan Luo
    Xiaolan Zhu
    Yanhui Liu
    Journal of Experimental & Clinical Cancer Research, 36
12345